OrbiMed raising $300M for Asian fund

OrbiMed Advisors is raising $300 million for OrbiMed Asia Partners II L.P., according to an SEC filling. OrbiMed's current Asian portfolio includes preclinical CRO Crown BioScience Inc., which is head...